Table 3.
Time to relapse by Kaplan-Meier analysis
|
Variable |
n |
Means of survival time (years) / n |
p-value, Log Rank |
|
|---|---|---|---|---|
| GASC1 negative | GASC1 positive | |||
| Overall |
355 |
12.9/198 |
14.8/157 |
0.034 (0.005B, 0.010T-W) |
| Age |
|
|
|
|
| <=55 |
172 |
12.9/107 |
14.9/65 |
0.168 |
| >55 |
183 |
12.9/ 91 |
14.5/92 |
0.098, (0.035 B, 0.052 T-W) |
| Tumor size |
|
|
|
|
| T1 |
168 |
14.8/ 92 |
15.6/76 |
0.331 |
| T2+T3+T4 |
187 |
11.1/106 |
13.9/81 |
0.040 (0.013B, 0.018 T-W) |
| Nodal status |
|
|
|
|
| negative |
193 |
15.5/111 |
16.6/82 |
0.135 |
| positive |
162 |
9.1/ 87 |
12.8/75 |
0.013 (0.002B, 0.004 T-W) |
| Clinical stage |
|
|
|
|
| I |
120 |
16.2/ 66 |
16.5/ 54 |
0.580 |
| II+III+IV | 230 | 11.1/130 | 14.0/100 | 0.014 (0.003 B, 0.005 T-W) |
p-value for test of equality of survival distributions for the different levels of GASC1, B: Breslow (Generalized Wilcoxon),T-W: Tarone –Ware, n – number of cases.